HEALTHJul 28 · 11:29 UTCSCMP CHINAEmily Hung

Hong Kong drives trials for breast cancer, eye treatments across Greater Bay Area

Hong Kong, Shenzhen, and Health Hope Pharma are collaborating on large-scale clinical trials for two US-developed treatments targeting breast cancer and a degenerative eye disease in the Greater Bay Area. The trials involve the Greater Bay Area International Clinical Trial Institute and its Shenzhen counterpart.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Health Hope PharmaorganizationDr Dennis Lam Shun-chiupersonGreater Bay Area International Clinical Trial InstituteorganizationShenzhenplaceGreater Bay Areaplace

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJul 15 · 14:03 UTC
CUHK launches first cross-border clinical trial centre in Nansha
HEALTHMay 31 · 11:00 UTC
Is Hong Kong winning the war on cancer or facing new battle in late diagnosis?
HEALTHMay 31 · 02:00 UTC
How a Hong Kong app is a ‘vital lifeline’ for 76,000 patients navigating cancer care
HEALTHJun 28 · 11:00 UTC
‘I see hope’: how mindset shifts help Hong Kong cancer patients cope with diagnosis
HEALTHJun 10 · 21:00 UTC
From Sick Care to Healthcare
HEALTHMay 31 · 13:00 UTC
‘Silent killer’: the race to beat cancer in Hong Kong